86 related articles for article (PubMed ID: 7524908)
1. Antibodies to hepatitis C virus in human immunoglobulins: clinical meaning and diagnostic difficulties in children undergoing bone marrow transplant.
Mateos ML; Camarero C; Maldonado S; Lasa E; Otheo E; Muñoz A
Bone Marrow Transplant; 1994 Jul; 14(1):95-7. PubMed ID: 7524908
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation.
Fujii Y; Kaku K; Tanaka M; Kaneko T; Matumoto N; Shinohara K
Bone Marrow Transplant; 1994 May; 13(5):523-6. PubMed ID: 7519934
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C infection in BMT patients.
Kolho E; Ruutu P; Ruutu T
Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation.
Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S
Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern.
Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F
Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents.
Sodeyama T; Kiyosawa K; Urushihara A; Matsumoto A; Tanaka E; Furuta S; Akahane Y
Arch Intern Med; 1993 Jul; 153(13):1565-72. PubMed ID: 7686741
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus in long-term bone marrow transplant survivors.
Ivantes CA; Amarante H; Ioshii SO; Pasquini R
Bone Marrow Transplant; 2004 Jun; 33(12):1181-5. PubMed ID: 15094751
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients.
Prohaska W; Wolff C; Schlüter K; Köster-Eiserfunke W; Körner MM; Kleesiek K
Clin Investig; 1992 Jul; 70(7):573-8. PubMed ID: 1327328
[TBL] [Abstract][Full Text] [Related]
9. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
11. Incidence and influence of GB virus C and hepatitis C virus infection in patients undergoing bone marrow transplantation.
Akiyama H; Nakamura N; Tanikawa S; Sakamaki H; Onozawa Y; Shibayama T; Tanaka S; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Bone Marrow Transplant; 1998 Jun; 21(11):1131-5. PubMed ID: 9645576
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
13. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of determination of anti-HCV antibodies].
Takase K; Tameda Y; Kosaka Y
Rinsho Byori; 1994 Oct; 42(10):1003-9. PubMed ID: 7527869
[TBL] [Abstract][Full Text] [Related]
15. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
Imamura S
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
17. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
19. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
